Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1
By: Daniela Muenzel, Heinz-Peter Engels, Melanie Bruegel, Victoria Kehl, Ernst Rummeny and Stephan Metz
Open Access
|Jan 2012References
- Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases - preliminary results.2010;: 92-6.
- Inan N, Kilinc F, Sarisoy T, Gumustas S, Akansel G, Demirci A. Diffusion weighted MR imaging in the differential diagnosis of haemangiomas and metastases of the liver.2010;: 24-29.
- Horvat M, Novakovic BJ. Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma.2010;: 232-8.
- Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.2000;: 205-16.
- Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).2009;: 228-47.
- Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.2004;: 257-60.
- Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.2003;: 2574-82.
- Darkeh MH, Suzuki C, Torkzad MR. The minimum number of target lesions that need to be measured to be representative of the total number of target lesions (according to RECIST).2009;: 681-6.
- Hillman SL, An MW, O'Connell MJ, Goldberg RM, Schaefer P, Buckner JC, et al. Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation.2009;: 3205-10.
- Zacharia TT, Saini S, Halpern EF, Sumner JE. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.2006;: 1067-70.
- Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I. RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma.2005;: 1426-30.
- Curran SD, Muellner AU, Schwartz LH. Imaging response assessment in oncology.2006;: S126-30.
- Shanbhogue AK, Karnad AB, Prasad SR. Tumor response evaluation in oncology: current update.2010;: 479-84.
- Gavrielides MA, Kinnard LM, Myers KJ, Petrick N. Noncalcified lung nodules: volumetric assessment with thoracic CT.2009;: 26-37.
- Creaney J, Francis RJ, Dick IM, Musk AW, Robinson BW, Byrne MJ, et al. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.2011;: 1181-9.
- Gietema HA, Schaefer-Prokop CM, Mali WP, Groenewegen G, Prokop M. Pulmonary nodules: interscan variability of semiautomated volume measurements with multisection CT - influence of inspiration level, nodule size, and segmentation performance.2007;: 888-94.
- Wang Y, de Bock GH, van Klaveren RJ, van Ooyen P, Tukker W, Zhao Y, et al. Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variability.2010;: 1180-7.
- De Vriendt G, Rigauts H, Meeus L. A semi-automated program for volume measurement in focal hepatic lesions: a first clinical experience.1998;: 181-3.
- Heussel CP, Meier S, Wittelsberger S, Gotte H, Mildenberger P, Kauczor HU. [Follow-up CT measurement of liver malignoma according to RECIST and WHO vs. volumetry]. [German].2007;: 958-64.
- Keil S, Plumhans C, Behrendt FF, Stanzel S, Suehling M, Muhlenbruch G, et al. Automated measurement of lymph nodes: a phantom study.2009;: 1079-86.
- Keil S, Plumhans C, Behrendt FF, Stanzel S, Suehling M, Muhlenbruch G, et al. Semi-automated quantification of hepatic lesions in a phantom.2009;: 82-8.
- Cowey CL, Fielding JR, Rathmell WK. The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response.2010;: 1108-13.
- Nathan PD, Vinayan A, Stott D, Juttla J, Goh V. CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies.2010;: 15-9.
- Smith AD, Lieber ML, Shah SN. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT.2010;: 157-65.
- Petralia G, Preda L, Giugliano G, Jereczek-Fossa BA, Rocca A, D'Andrea G, et al. Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume.2009;: 552-9.
- Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R, et al. High-grade soft-tissue sarcomas: tumor response assessment - pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.2009;: 447-56.
Language: English
Page range: 8 - 18
Published on: Jan 2, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2012 Daniela Muenzel, Heinz-Peter Engels, Melanie Bruegel, Victoria Kehl, Ernst Rummeny, Stephan Metz, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.